Nabriva Therapeutics plc (NBRVF)
OTCMKTS: NBRVF · Delayed Price · USD
0.0001
0.00 (0.00%)
Jul 9, 2024, 9:30 AM EDT - Market closed
Nabriva Therapeutics Market Cap
Nabriva Therapeutics has a market cap or net worth of $3.00 as of August 30, 2024. Its market cap has decreased by -100.00% in one year.
Market Cap
3.00
Enterprise Value
-1.64M
1-Year Change
-100.00%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since September 18, 2015, Nabriva Therapeutics's market cap has decreased from $262.20M to $3.00, a decrease of -100.00%. That is a compound annual growth rate of -90.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2023 | 45.50M | -21.42% |
| Dec 30, 2022 | 57.90M | -82.20% |
| Dec 31, 2021 | 325.30M | -10.85% |
| Dec 31, 2020 | 364.90M | -64.72% |
| Dec 31, 2019 | 1.03B | 5.76% |
| Dec 31, 2018 | 977.90M | -55.43% |
| Dec 29, 2017 | 2.19B | 1,630.44% |
| Dec 30, 2016 | 126.80M | -37.20% |
| Dec 31, 2015 | 201.90M | -23.00% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 864.43B |
| Novo Nordisk | 616.87B |
| UnitedHealth Group | 544.68B |
| Johnson & Johnson | 399.19B |
| AbbVie | 346.64B |
| Merck & Co. | 300.25B |
| AstraZeneca | 270.42B |
| Novartis AG | 243.48B |